{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for penicillin root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
INN:lorigerlimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03261739: Phase 1 Interventional Completed NAFLD
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04139902: Phase 2 Interventional Recruiting Melanoma Stage III
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab botidotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03700294: Phase 1 Interventional Terminated Advanced Solid Tumors
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03541369: Phase 1 Interventional Terminated Relapsed/Refractory Acute Myeloid Leukemia (AML)
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02890368: Phase 1 Interventional Terminated Solid Tumors
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02665065: Phase 3 Interventional Active, not recruiting Acute Myeloid Leukemia
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03633396: Phase 2 Interventional Completed Palmoplantar Pustulosis
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:boserolimab [INN]
Source URL:
Class:
PROTEIN
